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Abstract
Diffusion-weighted noble gas pulmonary magnetic resonance imaging (MRI) provides in
vivo images with a contrast uniquely sensitive to molecular displacement at cellular and
sub-cellular length scales. We estimated the external airway radius (R) and internal airway
radius (r) of the alveolar dimensions to evaluate potential differences in acinar duct
morphometries in healthy older never-smokers and compared those with a group of exsmokers. The acinar duct and alveolar MRI morphometry results were within the
physiologically-valid range of parameters. Estimated values of internal (r) and external (R)
airway radius as well as alveolar sheath (h) and mean linear intercept (Lm) for individual
subjects were similar with low variance. Results showed that MRI measurements of lung
air space size in healthy older never-smokers were elevated compared to previous results
reported in younger never-smokers, and lower than in age-matched ex-smokers (p<.05).
Specifically, older never-smokers had significantly lower external and internal airway
radius and mean linear intercept, but higher alveolar sheath thickness, alveolar density and
surface area-to-volume ratio than ex-smokers (p<.05). Such results are compatible with the
senile emphysematous changes to healthy parenchyma that accompany aging. These
results demonstrate the potential MRI has with regards to replacing histology and lung
stereology as the gold standard for measuring pulmonary acinus microstructure.

Keywords
Hyperpolarized 3He magnetic resonance imaging, functional lung imaging, diffusion
weighted imaging, lung microstructure, senile emphysema
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CHAPTER 1: INTRODUCTION

The senile lung can be characterized by a homogeneous enlargement of the alveolar
airspaces, without fibrosis or destruction of the alveolar walls. The objective of this chapter
is to provide an introduction to lung aging and the senile lung, as well as to provide an
overview of the historical and current techniques employed for measuring lung
morphometry.

1.1

Overview and Motivation

Chronic lower respiratory tract disease is the third leading cause of death in people aged
65 years and older.1 This disease, comprised of asthma, emphysema, chronic bronchitis,
bronchiectasis and chronic obstructive pulmonary disease (COPD), is more prevalent now
than ever before as a result of an ever-growing and aging population. With respect to
current demographic trends in North America, an understanding of how the body changes
with age and how this impacts the respiratory system is critical in order to improve the
quality of life of individuals as they approach old age. Moreover, this knowledge is
essential for reducing the potentially overwhelming burden that these respiratory diseases
place on the currently strained healthcare system.
As individuals age, a variety of structural and functional changes occur, including, but not
limited to, a reduction in maximal vital capacity and gas exchange, as well as a weakening
of the respiratory muscles and a deterioration of lung defense mechanisms. 2-6 As
detrimental as the aforementioned issues may sound however, these age-related changes
rarely present with symptoms on their own. It is true that these changes contribute to an
older person's reduced ability to do vigorous exercise, but more often than not, the limiting
factor for undertaking strenuous activities are age-related decreases in heart function.7,8
Instead, what is most important when considering the changes associated with lung aging
is not the reduction in maximal function, but rather the increased risk that these changes
place on older people that make them more vulnerable to respiratory failure and
hypoxia.9,10 Specifically, the risk of developing pneumonia after bacterial or viral
infections and the added complications associated with an already weakening set of lungs.
The fundamental premise for understanding the effects these changes have on an individual
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is that they disturb health through their ability to exacerbate the effects of heart and lung
diseases, and further complicate those caused by various environmental hazards such as
smoking or pollution.
Current knowledge of the mechanisms that influence pulmonary structure and function
with age is very limited. Even more limited is our understanding of the structural changes
that take place on the microstructural or alveolar level (the primary area for gas exchange
in the human lung).11 Existing measures of lung morphology are highly invasive, relying
predominantly on excised tissue or cadaveric samples. These techniques, such as lung
histology and stereology, depend on extensive user input, and as such are prone to
subjective bias as a result of opinions on topics such as sample selection or specimen
preparation techniques.12-14 Most importantly, the established techniques cannot provide in
vivo, individualized information on the nature of lung aging as it is taking place in the body.
Currently, the microstructural changes observed in the aging lung are referred to as senile
emphysema, and is characterized by an enlargement of the alveolar space without fibrosis
or tissue destruction.3 Unfortunately, there is limited information regarding the nature or
etiology of these changes, as well as their effect on quality of life. Thus, in order to combat
the impending pulmonary challenges of an aging population, non-invasive, reproducible,
and accurate methods for measuring lung microstructure are essential in furthering our
understanding of pulmonary development and deterioration.
This thesis focuses on the development and application of a direct, non-invasive
quantitative measurement of alveolar morphometry derived from hyperpolarized helium-3
(3He) diffusion-weighted magnetic resonance imaging (MRI) in a group of older neversmokers. This chapter reviews the literature regarding the anatomy of the human lung and
the physiological changes which occur with normal aging. Specifically, this section will
focus on the structural and functional changes that occur in the aging human lung, with an
emphasis on the nature of senile emphysema as it compares to COPD-related emphysema.
A survey of current lung morphometric tools is also included, with a look at the current
gold standard lung stereology, as well as two more novel techniques consisting of highresolution X-ray micro-computed tomography (micro-CT) and hyperpolarized
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diffusion MRI. Lastly, an overview of the hypotheses tested in this thesis regarding the
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nature and etiology of senile emphysema and its connection to COPD-related emphysema
are described, along with a summary of the overall objectives of this study.

1.2
1.2.1

The Lung
Anatomy and Microstructure of the Lung

The human lungs, consisting of both a left and right lung, are the essential organs for
respiration. The key role of the lungs is to bring oxygen (O2) into the body, and remove
carbon dioxide (CO2), the primary waste product. Figure 1-1 depicts an overview of the
main structures involved in the respiratory system.15 A double layered serous membrane
surrounds each lung, with the outer layer, parietal pleura, attached to the wall of the thoracic
cavity, and the inner layer, visceral pleura, covering the outside surface of each lung.16
Between these two layers is a region called the pleural cavity which creates space for the
lungs to expand into during inhalation. The entirety of the lungs are enclosed in and
protected by the rib cage. The right lung is comprised of three lobes (upper, middle, and
lower lobe), while the left lung is slightly smaller, having only two lobes (upper and lower
lobe) with an area designated for the heart known as the cardiac notch. The horizontal
fissure separates the upper and middle lobes, while the right oblique fissure separates the
middle and lower lobes in the right lung. In the left lung, the left oblique fissure separates
the upper and lower lobes.17

Figure 1-1: The Respiratory System. The biological system responsible for the intake
and exchange of oxygen (O2) and carbon dioxide (CO2).
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Air first enters the body when inhaled through the nose or mouth. From here, it travels
through the pharynx and larynx, where it eventually reaches the trachea. The trachea splits
into the left and right primary bronchus which feed each lung independently. These bronchi
can be described as large hollow tubes which are kept rigid by a series of cartilaginous
rings to prevent collapse and/or blockage of airflow to the lungs. The main bronchi branch
off into secondary bronchi which feed each lobe, and then into tertiary bronchi within each
lobe.15 Mucus is secreted onto bronchial surfaces via goblet cells which line the inner
surface of these bronchi.18 Ciliated columnar cells are also present and function together to
push mucus secreted by goblet cells out of the lungs. This cooperative mechanism, known
as the mucociliary elevator, enables the lungs to clear away dust, pathogens, viruses,
bacteria and fungi from the respiratory tract, trapping the contaminants in mucus which are
then carried by the cilia to the mouth where it is eventually swallowed or coughed up.2,19
Numerous small bronchioles branch off from the tertiary bronchi in each lobe. These
bronchioles differ from the preceding bronchi in part due to their smaller size, but most
significantly in the composition of their inner walls. These airways lack the stiff hyaline
cartilage rings found in bronchi, and are instead comprised of elastin fibers and smooth
muscle tissue.20 These characteristics enable the bronchioles to change their diameter
significantly in response to biological need, such as dilation during exercise or constriction
when exposed to environmental pollutants. The bronchioles continues to branch until they
become what are commonly known as terminal bronchioles which are located beginning
around the 16th generation (Figure 1-2).20,21 These bronchioles are amongst the smallest in
the lungs and terminate at the alveoli, signaling the end of what is known as the conducting
zone of the lung, compromised of the trachea, bronchi and conducting bronchioles.
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Figure 1-2: Human Airway Tree. Schematic of the human airway tree including the
conducting and respiratory zones.
Beginning around the 17th generation are the respiratory bronchioles, named as such due
to the alveoli which line their walls. Alveoli, the functional units of the lung, appear as
small hollow cavities, which permit gas exchange between air in the lungs and the blood
in the local capillaries (Figure 1-3).22,23 Inhaled O2 and exhaled CO2 diffuse between the
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alveolar space and local capillaries as a result of a steep concentration gradient which is
maintained by a combination of constant breathing and continuous blood flow in the
capillaries.24 Three major cell types make up the alveolar wall; Type I squamous alveolar
cells form the main structure of the alveolar wall, while Type II great alveolar cells secrete
pulmonary surfactant to aid in inflation of the alveoli, and lastly macrophages which
function to capture and phagocytize pathogens and other foreign material.25,26 By the 20th
generation, the entire airway is lined with alveoli, and these bronchioles are now referred
to as alveolar ducts. These ducts end around the 23rd generation in sacs lined with alveoli
and are consequently referred to as the alveolar sacs. The lungs contain approximately 300500 million alveoli, with a total surface area ranging from 50-100 square meters (roughly
the same size as an outdoor tennis court).22,27

Figure 1-3: Alveoli and Gas Exchange. Alveolar cellular composition and structure.
Total surface area available for gas exchange can range from anywhere between 50-100m2.
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1.2.2

Lung Function

Efficient ventilation of the lungs relies on the concerted efforts of the diaphragm and both
the external and internal intercostal muscles. This ventilation depends on the process of
negative pressure breathing which requires a pressure differential between atmospheric air
and that inside the alveoli.28 To accomplish this, muscles surrounding the lung expand and
contract to change the volume of the thoracic cavity. Inhalation (or inspiration) depends on
the active expansion of the thoracic cavity, in which there is contraction of both the
diaphragm and external intercostal muscles. These changes effectively lower intrathoracic
pressure while increasing intraabdominal pressure, ultimately drawing atmospheric air into
the lungs by raising the rib cage and moving the abdominal contents downwards and
outwards.20,26 In contrast to inhalation, exhalation is a predominantly passive process,
relying on the elasticity of pulmonary tissues to reduce the thoracic cavity size and expel
air from the lungs, with the assistance of the internal intercostal muscles during deep
exhalation.29
Total lung capacity (TLC) of a typical adult human is between 4-6 litres, with variations
depending on the combined effects of height, age, gender, and respiratory health.30,31
Figure 1-4 shows standard lung volumes resulting from normal and forced respiration. The
average human respiratory rate is 12-20 breath per minute.32 With each breath,
approximately 0.5 litres of air is moved into or out of the lungs, referred to as the tidal
volume, which equates to roughly 6-10 litres of air exchanged per minute.11,32 A resting
midpoint of the lungs is achieved when the inward elastic force reaches equilibrium with
the outward force of the thorax. This volume (approximately 2-3 litres in an average young
adult) is consistent with the functional residual capacity (FRC) of the lungs, and is the
volume of air present at the end of a normal tidal breath. During forced
inhalation/exhalation, or what is known as deep breathing, the volume of air exchanged
with each breath can reach anywhere from 3 to 5 litres, also known as the vital capacity
(VC) of the lungs.33,34 Regardless of the forcefulness of breathing, there remains at all times
approximately 1 litre of air in the lungs, referred to as the residual volume (RV).33
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Figure 1-4: Lung Volumes. Lung volumes of a healthy adult can be measured using
plethysmography and include vital capacity, tidal volume, expiratory reserve volume,
residual volume, inspiratory reserve volume, functional residual capacity and total lung
volume.

1.3
1.3.1

Lung Aging
Structural Changes

The lungs undergo significant and crucial developmental changes over the first two
decades of life. By the age of 12, the maximal number of alveoli has been reached, and
over the following decade the respiratory system rapidly approaches optimal functional
capacity. Unfortunately, after this period of accelerated growth (25 years for males, 20
years for females), the lungs begin a progressive decline in performance until death.35 The
major physiological changes that occur in the aging respiratory system may reflect several
mechanistic/structural changes such as: 1) diminished lung elasticity; 2) increased stiffness
of the chest wall; 3) a reduction in respiratory muscle strength; and 4) an overall change in
the shape and structure of the lung.5,36,37
Specifically, previous work by Knudson et al showed that there was decreased lung
elasticity with age in a group of never-smokers, aged 25-75.38 The cause of these changes
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is not well established since the concentrations of elastin and collagen do not change with
age. Specifically, lung elastin remains relatively stable over time, with a typical longevity
approaching decades.39 The reduced elastic recoil and diffusing capacity of the lung (a
measure of the transfer of gas from the lungs to the surrounding blood vessels) is believed
to be a result of stress relaxation of elastin-fibers as evidenced by an apparent increase in
thickness along with the appearance of more loosely associated fibers.40 A disruption in
collagen fibers leading to an increase in intermolecular crosslinks has also been postulated
to result in diminished elastic recoil; however there is limited and conflicting evidence to
support this theory at present.41
Another factor contributing to the deterioration of lung function with age is decreased chest
wall compliance. As the body ages, the rib cage along with various associated points of
articulations experience calcification resulting in increased stiffening.3,42 Additionally,
osteoporosis can also lead to changes in the shape of the thorax, resulting in a phenotype
commonly known as a “barrel chest”. The changes in chest wall compliance along with the
kyphotic curvature of the spine with age both contribute to the deformation of the
diaphragm leading to a reduction in its force-generating capabilities.5,42 The general
reduction in overall muscle mass, specifically type II fast twitch fibers, as well as a loss of
peripheral motor neurons and corresponding alterations in neuromuscular junctions also
contributes to a significant reduction in respiratory muscle strength.43
With regard to lung development and maturation, the large airways remain relatively stable
in terms of abundance and diameter. Smaller airways however begin to narrow, and there
is actually a loss in the number of total airways present in the lung.44 The disappearance
of smaller airways appears related to a loss of supporting connective tissue which results
in frequent collapse of weakened alveolar ducts.3 A number of structural changes occur
within the aging alveoli as well. Studies have shown that the average distance between
airspace walls increases (Lm, mean linear intercept) and alveolar pores become much
larger45, while the alveoli themselves become much shallower.3 These changes are also
associated with an increase in alveolar septal thickness, leading to a uniform pattern of
airspace dilation and overall reduction in total lung surface area.46
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1.3.2

Functional Changes

The underlying structural changes that occur in the aging lung affect all levels of lung
function, including dynamic flow rates, static lung volumes and alveolar gas exchange
rates. Most of what is known regarding changes in lung function with age comes from
cross-sectional studies which rely on pulmonary function tests (PFTs). Our current
understanding of lung function decline with aging stems from work done by Fletcher et al
in 1977. This work showed a continuous decline in the forced expiratory volume in 1
second (FEV1) at a rate of roughly 42 ml/yr beginning between the ages of 25 and 30
(Figure 1-5).47 Various more recent longitudinal cross-sectional studies have validated
these findings and shown that the rate of loss is greater in males than in females.42
Additionally, forced vital capacity (FVC) has been shown to steadily decrease to around
75% of peak-value. Together with the age-related changes in FEV1, this results in an
overall decrease in the FEV1/FVC ratio to around 70-75% by the age of 70, as FEV1
declines more rapidly than FVC.48,49

Figure 1-5: Pulmonary Function Declines in Normal Aging and COPD. Lung function
declines in COPD hypothesized as an accelerated form of aging. Adapted from work by
Fletcher & Peto and Ito & Barnes.47,50
With regards to static lung volumes, the age-dependent reduction in elastic recoil has been
shown to lead to an increase in RV as a result of gas trapping, by approximately 50% up to
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the age of 70.51 The combination of the chest wall becoming less compliant along with
lungs becoming more distensible has also been shown to increase FRC. This increase in
residual capacity cause older subjects to breath at higher lung volumes than normal which
places an additional burden on the respiratory muscles.52 Studies in elderly subjects have
shown that during resting tidal breathing these changes can result in a 20% increase in
breathing-related energy expenditure as compared with a 20 year-old subject.42
Interestingly, TLC does not change significantly with age, as stiffening of the chest wall
has been shown to counterbalance the decrease of elastic recoil in the lungs.5,53
The diffusing capacity of the lung has also been shown to decrease markedly with age.54
Recent studies have shown a decline in the diffusing capacity of the lungs for carbon
monoxide (DLCO) to values approximately two-thirds of those predicted for otherwise
healthy young adults.53,54 Several factors are thought to explain this drastic drop in
diffusing capacity, with the most common theories being a decrease in the efficiency of
pulmonary ventilation and a loss of alveolar surface area combined with reduced blood
flow in pulmonary capillaries. Studies have shown however that the density of pulmonary
capillaries remains unchanged with age, and thus the most significant factor influencing
this decline appears to be the reduction of alveolar surface area.55,56

1.3.3

Imaging Studies of the Aging Lung

Presently, there is limited literature available in the field of pulmonary imaging of older
never-smokers. The majority of studies have predominantly applied non-invasive imaging
tools to differentiate ex-smokers with COPD from control groups of older never-smokers.
These studies aimed to develop a deeper understanding of lung structure and function of
the diseased lung, while ignoring the unique characteristics and traits of the presumably
healthy aged lung. A number of reasons may exist for the lack of data in older subjects,
with one explanation being the added difficulty in working with elderly patients as opposed
to younger subjects. Specifically, simple positioning of the patient requires more time, and
often patients need assistance and increased supervision.57 This need for more time and
staff limits the practicality of research in the elderly. In addition to these constraints, agerelated factors such as poor renal function limit the use of many contrast agents when
performing computed tomography (CT) or MRI, due to the increased risk of nephrogenic
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systemic fibrosis.58 Further complicating matters are the presence of contra-indicators such
as cardiac pace makers or older ferromagnetic surgical material which severely restrict the
use of imaging techniques such as MRI.57
When studying the elderly, it is especially important to separate the normal process of aging
from the presence of disease itself. In some cases, differentiation may not be possible
without extensive imaging or invasive procedures. Normative structural or functional
values are sparse or not well described in the literature, with age-related changes in airspace
size and fibrosis typically described as moderate.
One example of the ambiguity regarding normal aging and disease is the common finding
of moderate basal lung fibrosis, which may be due to age-related changes or interstitial
lung disease.3,57 A differentiation of these findings is important as it can mean the
difference between a specific treatment and a non-interventional approach as would be the
case with simple age-related changes. Therefore, close correlation between the
morphological extent of the fibrotic changes, clinical history, and observation of associated
changes is essential. Another example of the ambiguity between disease and the normal
aging occurs in the case of airspace enlargement evident using a number of imaging
modalities such as CT and noble gas MRI. The finding of senile emphysema is usually not
accompanied by the clinical findings of COPD-linked emphysema, such as breathlessness
on exertion, and these difference are further outlined in Chapter 1.3.4.
A recent study by Copley et al. aimed to describe thin-section pulmonary CT features in a
group of asymptomatic elderly subjects. Their results showed that there were a large
number of elderly asymptomatic adults (> 75 years) with centrilobular emphysematous
changes in CT imaging as compared to a younger control group (< 55 years).59 In the same
study, interstitial changes of the lung with a sub-pleural reticular pattern was found in 60%
of the elderly patients, which was completely absent in the younger group. Additionally,
25% of the elderly asymptomatic patients showed small cysts. A related study by Lee et al.
also using thin-section CT showed an increase in air trapping with age, with a significant
proportion of subjects (50%) being asymptomatic.60
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More recently, a study by Sheikh et al. looked to utilize noble gas MRI to better understand
the determinants and physiological consequences of ventilation defects in older neversmokers. To do so, they evaluated pulmonary function and cardiopulmonary exercise test
measurements (CPET) in a group of 52 older-never smokers (mean age 71 years). This
study represents the first large imaging study of healthy older never-smokers without a
history of chronic heart or lung disease. Interestingly, the study found that while a minority
of subjects reported occupational exposures, most subjects had visually obvious ventilation
defects that were not resolved following administration of salbutamol.61 The ventilation
defects were modest (~5%) and predominantly observed along the periphery of the lung
suggesting that terminal airway closure or narrowing may be a normal age-related
pulmonary finding. Additionally, there were no differences in CPET or dyspnea
measurements between subjects with and without ventilation defects, supporting the notion
that cardiovascular, and not respiratory factors, dominate exercise limitations.8 From these
findings, it is evident that there are physiological changes occurring in the aging lung that
are poorly understood, and as such would benefit from a more thorough evaluation of
pulmonary microstructure.

1.3.4

Senile Emphysema and COPD-related Emphysema

The senile lung can be characterized by a homogeneous enlargement of the alveolar
airspaces, without fibrosis or destruction of the alveolar walls. Morphometric studies have
shown that in subjects with senile emphysema, there is an increase in the mean linear
intercept as well as a decrease in the surface area of airspace wall per unit of lung volume
(S/V) as shown in Figure 1-6.46,52 Classical studies of the age-associated changes in lung
structure in 1958 found that these changes only became clinically demonstrable after the
age of 80 and were predominantly associated with women.62 A more recent study by
Gillooly and Lamb in 1993 however, found evidence of increased airspace enlargement
with age in all subjects.63 Additionally, there is homogeneous degeneration of the elastic
fibers around the alveolar duct starting around the age of 50, as well as reduction in
supporting tissue which results in premature closure of small airways during normal
breathing and can potentially cause air trapping and hyperinflation.9,63
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Figure 1-6: Histopathology in Masson Trichrome Stained Human Lung Parenchyma
Showing Alveolar Space. Normal lung tissue with Lm=0.279mm (left) and senile lung with
Lm=0.532mm (right) at 6x magnification. Adapted with permission.3
The term senile emphysema is often considered to be a misnomer, as subjects do not
express the symptoms of clinical emphysema, and hence this condition is more correctly
referred to as senile lung. Importantly, subjects with senile lung appear to have sufficient
lung function for their normal day-to-day activities.62 These changes do however increase
the risk of breathlessness and respiratory failure in the elderly when compromised, and
further complicate health when combined with cardiac impairment or respiratory
infection.9,10,64 Specifically, these age-dependent structural and functional changes can
reduce sensitivity of the respiratory centres in the presence of hypoxia or hypercapnia,
resulting in a diminished ventilatory response in cases of heart failure or aggravated
airways obstruction.5,10,65
In contrast to the senile lung, emphysema, as first described by Laennec in 1834, is
characterized by the dilation and destruction of lung tissue in regions following the terminal
bronchioles.66 In emphysema, the alveoli become deformed, changing into large irregular
pockets with reduced surface area for gas exchange with the pulmonary capillaries.67 Two
common forms of emphysema are frequently described in smokers. The first, and most
typical form, is called centrilobular emphysema, which is defined by an uneven pattern of
tissue destruction predominantly in the upper lobes.68-70 The second form is known as
panlobular emphysema, and is conversely defined by a more homogeneous pattern that is
more closely related to genetic disorders as opposed to smoking history or environmental
exposures.69,70 COPD-related emphysema is typically quantified and diagnosed using CT
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measures of attenuation. Specifically, this technique uses a cut-off threshold of -950
Hounsfield units for separating emphysematous tissue from normal healthy tissue.71,72
It is important to note that current guidelines for COPD based on the Global Initiative for
Obstructive Lung Disease (GOLD) lists a post-bronchodilator FEV1/FVC < 70% as the
threshold for diagnosis of airflow obstruction. The classical epidemiologic studies of
Fletcher and Peto demonstrated that death and disability from COPD were related to an
accelerated decline in lung function with time, with a loss of 50 to 100 mL in FEV1 per
year, but even in healthy volunteers there is a loss of 20 mL per year with aging resulting
in the aforementioned drop in FEV1/FVC to around 70-75% by the age of 70 (Figure 15).50 In this sense, many subjects will be classified as having airways obstruction by the
age of 70 simply as a result of the normal aging process.
Although the changes associated with senile emphysema are histologically different from
COPD related emphysema, they result in similar changes in lung compliance and function.
A consequence of the reduction in supporting tissues around the airways is a tendency for
the smaller airways to collapse. As a result, premature closure of these airways (<2mm)
becomes common during normal tidal breathing. Furthermore, the flattening of the internal
surface of the alveoli is associated with a reduction in alveolar surface (75 m2 at age 30 yrs
and 60 m2 at age 70 yrs, ~ -0.27 m2/yr).5,42 To date, a number of advanced techniques have
been developed and implemented to better measure and visualize pulmonary
microstructure. These techniques, which are detailed in the following section, provide an
opportunity to better understand the unique changes in alveolar microstructure which occur
in the aging lung.

1.4
1.4.1

Techniques for Measuring Lung Morphometry
Lung Stereology

Stereology, the gold standard technique for measuring lung morphometry, is the
quantitative characterization of three-dimensional (3D) objects based on measurements
made from two-dimensional (2D) cross-sections.73 One of the defining characteristics of
this technique is that it does not depend on any assumptions regarding the shape, size,
orientation, or spatial distribution of the object being studied. The technique is founded on
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the principles of stochastic geometry and relies on sampling structures with geometric
probes.74,75 The first implementation of these principles occurred in 1843 by mining
geologist Delesse who developed a stereological technique to determine volume fraction
from area fraction on sections.
Stereology consists of two important stages: sampling and measurement. With regards to
sampling, unbiased techniques must be applied at all levels of the analysis. Randomization
of both orientation and location of each specimen is also imperative for accurate and precise
measurements. The measurements at the final level of sampling are performed using
geometric probes as described in Table 1-1. The basic rule is that the dimension of the
parameter of interest plus the dimension of the geometric probe used for measurement has
to sum to three or greater, according to the values assigned in Table 1-1.73
Table 1-1: Relationship of Structural Quantities and Stereological Properties

Parameter

Appearance
in 2D Space

Probe

Event

Measurement

Volume,
𝑽𝒗 (3)

Area (2)

Surface
Area, 𝑺𝒗
(2)

Boundary (1)

Line, 𝐿𝑇
(1)

Line
intersects
surface

Intersection
count, I(x)

Point (0)

Plane,
𝐴𝑇 (2)

Plane
transects
line

Transect
count, Q(x)

-

Volume,
𝑃 𝑇 −𝑡 (3)

Dissector
volume
'hits'
particle top

Top count, Q(x)

Length, 𝑳𝒗
(1)

Number,
𝑵𝒗 (0)

Point, PT Point lies in
(0)
volume

Point count,
P(x)

Density
Estimate
𝑉𝑣 (𝑥)
= 𝑃(𝑥)⁄𝑃𝑇
𝑆𝑣 (𝑥)
= 2 ∙ 𝐼(𝑥)⁄𝐿𝑇
𝐿𝑣 (𝑥)
= 2 ∙ 𝑄(𝑥)⁄𝐴𝑇
𝑁𝑣 (𝑥)
= 𝑄 − (𝑥)⁄𝑃 𝑇 −𝑡

Stereology has seen use in a broad array of disciplines, from geology (i.e. measuring the
fraction of quartz in a rock sample) to medical science (i.e. estimating the total length of
capillaries per unit volume of tissue and measuring alveolar density of pulmonary tissue).
In fact, the adage that the human lungs have a surface area equivalent to that of an average
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tennis court was first derived using stereological methods. Datasets for lung stereology are
typically acquired using light or electron microscopy, but can also be collected using other
imaging modalities such as immune-electron microscopy,76 micro-computer tomography77
and scanning laser optical tomography.78
Both the American Thoracic Society (ATS) and the European Respiratory Society (ERS)
have defined standards for quantitative assessment of lung morphometry using
stereological techniques.79 Of particular note however, is the use of stereological
techniques to measure and assess various forms of pulmonary disease. Emphysema has
routinely been studied using stereological techniques such as those shown in Figure 1-7,
however most work has ignored the effects of septal destruction, and looked solely at
airspace enlargement.80 Typically this omission is due to the ease in which stereological
parameters for airspace enlargement can be acquired. Generally, mean linear intercept (Lm),
or mean linear chord length, is used to measure and asses changes in alveolar space.
Unfortunately, these parameters can be influenced by various factors such as inflation
pressure during fixation and tissue shrinkage after excision. Many morphometric
parameters can be easily misinterpreted or skewed if sample preparation is not highly
controlled.81 Loss of elastic recoil, a common physiological change in emphysematous and
aging lungs, can further complicate the measurement of airspace size as inflation pressure
will have a greater effect on alveolar expansion during specimen fixation. This
complication can lead to erroneous evidence of emphysema, even in the absence of disease,
as any reduction in the elastic properties of the lung may result in increased airspace
volume.82 Besides the aforementioned inflation related difficulties, serial sectioning of
multiple thin slices from tissue specimen is slow, expensive, and can distort the
microanatomy. These problems are further exaggerated by fixation techniques which have
the potential to alter lung tissue, and denature proteins such as collagen and elastin prior to
analysis.
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Figure 1-7: Quantitative Assessment of Morphometric Parameters in Emphysema.
A) combined estimation of alveolar luminal (A), ductal airspace (D), and septal (S) volume
as well as alveolar septal surface area; B) point-sampled intercepts method; C & D)
estimation of the Euler number. Adapted with permission.82

1.4.2

High-resolution X-ray Micro-computed Tomography

Since its introduction in the 1970’s, x-ray CT has rapidly become the gold standard imaging
tool for evaluating pulmonary microstructure. This technique offers the possibility of
studying lung microstructure on the basis of the inherent contrast offered by the radiodensity differences of tissue structures to air. Briefly, x-ray CT collects a series of image
slices compromised of a matrix of pixels (voxels), which are then assigned a specific value
(Hounsfield unit; HU) based on the x-ray attenuation signal as compared to that of
water.83,84 Studies of COPD subjects with emphysema agree with histological
measurements, presenting evidence of increased airway wall area dimensions85-87 as well
as increased percentage of low attenuation areas.88,89 Unfortunately, due to the limitation
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of standard clinical CT scanners, the smaller airways (<2mm) cannot be resolved. This
limitation is quite significant as the small airways are the major site of airflow obstruction
in COPD. As such, the applicability of standard CT for measuring alveolar microstructure
is quite limited.71
Micro–computed tomography (micro-CT) has rapidly emerged as an imaging technique
with the potential to measure lung microstructure on length scales much smaller than
previously possible with clinical CT scanners. Depending on the x-ray source, focus size,
voltage, sample volume, geometric magnification of the optical system, and resolution of
the charge-coupled device camera, a spatial resolution of 1-2 μm may be obtained.90,91 This
technology consequently offers the ability to analyze acinar morphometry without the need
for physical segmenting, thus maintaining an undamaged, 3D structure.92
Recent work by Tsuda et al. and Schittny et al. in 2008 demonstrated the potential of microCT to measure alveolar septa in rats93,94, while its ability to visualize and quantify lung
morphometry has also been demonstrated in both mouse95 and pig models.96 A number of
studies have also recently assessed the practicality of this technique using cadaveric human
lung specimens; however, most are conducted with a minimal sample size and/or the
omission of any quantitative analysis (Figure 1-8).97,98

Figure 1-8: Micro-CT of Human Lung Parenchyma. Normal lung parenchyma (left),
and centrilobular emphysema (right) showing enlarged alveoli and absent alveolar septa.
Field of view is 4mm. Adapted with permission.97
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With micro-CT imaging, acquiring a complete digital data set of a human lung specimen
is now possible. As a non-destructive approach, micro-CT allows analysis of acinar
characteristics such as volume, branching, branch length, and surface, over the entire area
of interest. Unfortunately, due to the long exposure time and high dose associated with this
technique, scanning living organisms is difficult, if not altogether impossible, limiting this
modality to use in either ex vivo or small animal model studies. When used to study human
lungs, the required radiation dose can only be safely applied to isolated lung samples, while
the cost of the procedure itself limits its use to only a small number of total specimens.
Various inflation and fixation techniques also introduce a variety of error and/or subjective
biases when using this technique.98 Furthermore, when stretching the limits of the system,
it can become difficult to determine whether airways with diameters smaller than the
achievable resolution are in fact non-existent or simply too narrow to detect via CT.99 These
barriers make micro-CT a highly invasive imaging modality that is unable to capture
longitudinal in vivo measurements of the aging lung.

1.5
1.5.1

Measuring Lung Morphometry with MRI
Magnetic Resonance Imaging

MRI relies on the magnetic properties of specific nuclei (most commonly hydrogen
protons) in order to create structural or functional images. When these nuclei are placed in
a magnetic field and stimulated by radio waves of a particular frequency, they emit radio
signals, which can then be used to create an image. Although MRI has a number of
advantages over CT, specifically a lack of ionizing radiation and increased soft tissue
contrast, the lungs pose a number of unique difficulties for this technique. Since healthy
lungs are comprised of 70% air, there is an especially low hydrogen density, making it
extremely difficult to acquire any information using conventional proton MRI.100,101 In
addition to this limitation, cardiac and respiratory motion, as well as artifacts resulting from
countless air/tissue interfaces hamper the ability of proton MRI to provide novel visual or
functional information.102 Acquiring images under specific breath-hold conditions can help
mitigate some of these motion artifacts, however they put severe constraints on image
acquisition duration. New proton-based imaging techniques have been designed to help
navigate many of these imaging obstacles. One such technique is ultra-short echo time
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(UTE) MRI, which limits signal loss in lung parenchyma due to the exceedingly short
apparent transverse relaxation time (T2*).103,104 By utilizing faster pulse sequences that
employ shorter echo times (TE), MR images can be acquired with diagnostic quality
comparable to that of CT.105

1.5.2

Hyperpolarized Noble Gas MRI

Hyperpolarized noble gas MR techniques have been studied for the past two decades, and
were first developed in 1994 by Albert et al.106 This technique relies on the use of either
hyperpolarized 3He or 129Xe gas as a contrast agent for functional MR imaging of the lung.
3

He, with a gyromagnetic ratio of 32.4MHz/T, has long been the contrast agent of choice,

with the potential to provide significant signal intensity after sufficient polarization.
In recent years, 3He MRI has been used to study both pulmonary structure and function in
a variety of diseases such as COPD107-109, asthma110-112, cystic fibrosis113-115 and lung
cancer116. The technique primarily focuses on two major measurements, ventilation defect
percent (VDP)61,117 and apparent diffusion coefficient (ADC).118-121 In particular, ADC
measures helium diffusivity in the lungs due to Brownian motion, with alveoli representing
the elementary geometrical unit. The first demonstration of diffusion spectroscopy was
performed in 1965 by Stejskal and Tanner.122 They showed that in the presence of two
opposite-polarity gradient pulses, nuclear spins suffer a net phase shift that is proportional
to their displacement during the length of the applied pulse plus lobe separation (diffusion
time), resulting in a decreased signal amplitude. In the case of free (Gaussian) diffusion
(D0), the MR signal decays according to equation (1):
𝑆𝑖𝑔𝑛𝑎𝑙 = 𝑆𝑖𝑔𝑛𝑎𝑙0 exp(−𝑏𝐷0 ),

(1)

where Signal0 is the MR signal intensity in the absence of diffusion-sensitizing gradients.
In the presence of internal barriers, such as alveolar walls within the lung, diffusive motion
of the gas is restricted and the MR signal decay is described in terms of the ADC as in
equation (2):
𝑆𝑖𝑔𝑛𝑎𝑙 = 𝑆𝑖𝑔𝑛𝑎𝑙0 exp(−𝑏𝐴𝐷𝐶)

(2)
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Unlike the free diffusion scenario, the ADC for restricted diffusion depends on a
combination of molecular properties of the gas, tissue structure and shape of the gradient
waveform. The b value is proportional to the gyromagnetic ratio of the gas (𝛾), gradient
lobe amplitude (𝐺𝑚 ), ramp up/down time (𝜏), duration of the lobe (𝛿), and the diffusion
time (Δ) according to equation (3)123,124:
𝛿
7
8
𝑏 = (𝛾𝐺𝑚 )2 [𝛿 2 (Δ − ) + 𝜏 (𝛿 2 − 2Δ𝛿 + Δ𝜏 − 𝛿𝜏 + 𝜏 2 )]
3
6
15

(3)

Studies using this technique have shown that as the lungs age, structural changes occur and
result in an annual increase in the ADC of 0.0015cm2/s for subjects between 20 and 70
years of age from a baseline ADC of 0.20cm2/s in healthy young adults.125,126 The 3He
ADC technique has also been shown to be highly reproducible127-129, with a significant
correlation with both CT measurements of emphysema111,130,131 and histological
measurements of airspace size.132 Studies of asymptomatic smokers without COPD have
shown elevated ADC measurements, suggesting that the 3He MR technique may provide a
sensitive measure of lung tissue destruction before the onset of clinically detectable
symptoms.131,133 Recent studies have developed this technique even further, collecting
multiple diffusion weighted images in order to measure geometric parameters
(morphometry) within the alveolar space itself.134-140
The 3He MR morphometry technique relies on previous work by Weibel and HaefeliBleuer who describe the structure of acinar airways as branching trees.141,142 In this model,
the airway tree begins at the trachea, and proceeds through the bronchi and bronchioles to
the terminal bronchioles which feed each acinus. Gas ventilation in the conducting airways
occurs predominantly by bulk flow (convection), whereas diffusion is the primary
mechanism of ventilation beyond the terminal bronchioles in the acinus.20 The acinus is
commonly defined as the largest airway unit in which all airways participate in gas
exchange, and represents the complex of all airways distal to the terminal bronchiole,
beginning with the primary respiratory bronchioles. A number of studies have adapted and
simplified the Weibel model. This adapted model, known as the ‘cylinder model’, is
commonly used in the 3He MR morphometry technique, and describes the airways within
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the acinus as cylinders covered by alveolar sleeves, due to the high concentration of alveoli
decorating the walls of these airways (Figure 1-9).134,142-145

Figure 1-9: Schematic Structure of Two Levels of Acinar Airways. Geometrically,
each acinar airway can be considered a cylindrical tube surrounded by an alveolar sleeve.
DT, transverse diffusion; DL, longitudinal diffusion; L, alveolar length; R, external airway
radius; r, internal airway radius; h, alveolar sheath.
The technique for measuring alveolar microstructure was pioneered by Yablonskiy and
Sustanskii which considers airways, as opposed to alveoli, as the elementary geometrical
units.134 Diffusion within the airways is anisotropic (direction-dependent), resulting in
diffusion rates along and across terminal airways to be independently determined by
equation (4)146:
𝐴𝐷𝐶(𝛼) = (𝐷𝐿 cos 2 𝛼 + 𝐷𝑇 cos2 𝛼),

(4)

where α is the angle the principal axis is tilted from the field gradient direction, DL is the
longitudinal diffusion coefficient, and DT the transverse diffusion coefficient. This angle,
α, is crucial as impediments along the airway (longitudinally) are much smaller than those
across (transverse). The alveolar walls, ducts, and other branches of the airway tree act as
obstacles to the diffusing helium 3He atoms. However, with a spatial resolution in the
millimetres currently achievable with 3He MRI, each imaging voxel contains hundreds of
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airways of various orientations. Thus, with these limitations, the model assumes that acinar
airways are isotropically distributed over a given imaging voxel, and consequently
microscopically anisotropic but macroscopically nearly-isotropic.
For each airway, the signal attenuation is exponential with respect to the b-value. Due to
the dependence of ADC on orientation angle however, the signal decay becomes nonexponential when summing the signal from all airways within a given voxel. Sustanskii
and Yablonskiy compare this mathematical problem to that of water diffusion in randomly
oriented uniaxial layers as described by Callaghan in 1991.146 The large number of airways
within each voxel allows the orientation distribution function to be assumed uniform, with
signal described by equation (5):
̅) (
𝑆𝑖𝑔𝑛𝑎𝑙 = 𝑆𝑖𝑔𝑛𝑎𝑙0 exp(−𝑏𝐷

𝜋
)
4𝑏𝐷𝑎𝑛

1⁄
2

exp (

𝑏𝐷𝑎𝑛
1
) 𝛷 [(𝑏𝐷𝑎𝑛 ) ⁄2 ]
3

(5)

̅ (mean ADC) and 𝐷𝑎𝑛 (anisotropy of
where Φ(x) is the error function, and the quantities 𝐷
ADC) are described by equations (6) and (7) based on geometrical the characteristics of
acinar airways147:
1
2
̅ =  𝐷𝐿 + 𝐷𝑇
𝐷
3
3

(6)

𝐷𝑎𝑛 = 𝐷𝐿 − 𝐷𝑇

(7)

It is important to note that when using this technique to measure pulmonary microstructure,
the diffusion time must be selected such that the root mean squared diffusion in one
direction is larger than the average alveolar radius, but smaller than the mean length of a
typical alveolar duct. In doing so, gas atoms are expected to diffuse away from their
originating alveoli, yet remain in the same alveolar duct during the duration of the diffusion
sensitizing gradient.140 This constraint recognizes acinar airways, including respiratory
broncheoli, alveolar ducts and alveolar sacs, as the elementary geometrical units
contributing to the gas diffusion MR signal. Under these conditions, larger conducting
bronchioles play little role in the diffusion MR signal formation. Equation (5) assumes that
all airways in a given voxel have the same geometric parameters and diffusion coefficients.
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As such, in order to minimize the number of parameters, the model assumes that the DL
and DT for each voxel already represent averaged values.
A detailed description of the 3He MR morphometry procedure is shown in Figure 1-10.
Briefly, the technique relies on fitting equations (5), (6), and (7) to multiple b-value
measurements of the 3He diffusion-attenuated MR signal which in turn make it possible to
evaluate mean geometrical parameters using a number of phenomenological expressions
previously derived through Monte Carlo simulations.147,148 These equations connect 𝐷𝐿 and
𝐷𝑇 to the characteristic diffusion length in one dimension (L1) of 3He in the lungs, as well
as morphometry parameters of external airway radius (R) and internal airway radius (r) as
described in figure 1-9 and equations (8)-(10).
𝐿1 = (2𝐷0 ∆)1⁄2
𝐷𝐿
𝑟 𝑅
= 𝐹𝐿 (𝑏𝐷0 , , )
𝐷0
𝑅 𝐿1
𝐷𝑇
𝑟 𝑅
= 𝐹𝑇 (𝑏𝐷0 , , )
𝐷0
𝑅 𝐿1

(8)

(9)
(10)

From these values, other physiological parameters can be calculated using equations (11)(14) from Yablonskiy et al.135:
𝐿 = 2𝑅 sin

𝜋
8

(11)

2
2
𝑆⁄ = 2𝜋𝑅 · 𝐿 + 2𝜋 · (𝑅 − 𝑟 ) + 16(𝑅 − 𝑟) · 𝐿,
𝑉
𝜋𝑅 2 𝐿

(12)

𝐿𝑚 = 4 · 𝑉⁄𝑆

(13)

𝑁𝑎 = 1⁄(𝜋𝑅 2 𝐿)

(14)

where L is alveolar length, 𝑆⁄𝑉 is the surface area (S)-to-volume (V) ratio of the alveoli,
Lm is the mean linear intercept, 𝑉 ⁄𝑆 is the volume (V)-to-surface area (S) ratio, and Na is
alveolar density. Previous studies have shown a close agreement between alveolar
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parameters obtained using the

3

He MRI lung morphometry technique and those

measurements found by direct histological analysis.134,135,139

Acquire
Diffusionweighted MRI
(5 b-values)

Generate Threshold
Mask to Remove Trachea
and Noise (b0 image)

Apply Threshold
Mask Across all bvalues for the Same
Slice

Fit Eqn’s (5-7) to Signal from
Multiple b-value Measurements
on a Voxel-by-Voxel Basis

Output Anisotropic
Diffusion Coefficient
̅ , Dan, DL, DT)
Maps (𝐷

Fit Anisotropic Diffusion Maps to
Yablonskiy and Sustanskii Derived
Expressions for Morphometry
Parameters on a Voxel-by-Voxel
Basis Using Eqn’s (8-10)

Output
Morphometry Maps
of Internal (r) and
External (R) Airway
Radii

Calculate Physiological Parameters
from r and R using Eqn’s (11-14)

Output Physiological
Parameter Maps (h, L, S/V,
Lm, and Na)

Figure 1-10: Process Diagram for Deriving Physiological Parameters from 3He
Diffusion-weighted MRI. All threshold and fitting procedures were performed using a
̅ , mean diffusion
custom-built IDL 6.4 algorithm. b0, non-diffusion-weighted image;𝐷
coefficient; 𝐷𝑎𝑛 , anisotropic diffusion coefficient; 𝐷𝐿 , longitudinal diffusion coefficient;
𝐷𝑇 , transverse diffusion coefficient; R, external airway radius; r, internal airway radius; h,
alveolar sheath; L, alveolar length; S/V, surface area-to-volume ratio; Lm, mean linear
intercept; Na, alveolar density

1.6

Research Hypothesis and Objectives

The hypothesis that we test in this thesis is that older never-smokers will have a
significantly increased external airway radius (R) and mean linear intercept (Lm), as well
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as decreased alveolar sheaths (h) similar to ex-smokers with mild COPD. The primary
objective of this thesis was to generate and evaluate 3He MR morphometry measurements
in a group of older never-smokers in order to build upon previous hyperpolarized noble gas
lung imaging studies of the senile lung. The aim was to develop and apply a non-invasive
method for measuring lung morphometry in a group of older-never smokers. By applying
the 3He diffusion weighted technique, I acquired estimates of alveolar airspace dimensions
and compared those to values calculated for a comparator group of ex-smokers. Previous
studies observed that there were mild peripheral ventilation defects in a large number of
older never-smokers. However, these defects did not contribute to decreased exercise
capacity or dyspnea. The current study aims to take a closer look at alveolar microstructure
and assess the structural and functional changes that occur in normal lung aging and
determine their relationship with standard pulmonary function measurements.
The last chapter of this thesis will provide an overview and summary of the important
findings and conclusions of Chapter 2. The study specific limitations as well as general
limitations of the use of hyperpolarized gas MRI will be discussed in addition to the
potential alternatives or solutions to these issues. Finally, based on the findings and
limitations discussed, a roadmap for future hyperpolarized noble gas MRI studies for use
in assessing alveolar microstructure will be addressed.
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2

CHAPTER 2: MULTIPLE B VALUE 3HE MRI OF
OLDER NEVER SMOKERS

To better understand the senile lung and the morphometric changes that occur with age,
here we evaluated a group of older never-smokers as well as a small group of ex-smokers
using hyperpolarized 3He diffusion weighted MRI to provide quantitative measurements of
lung morphometry.

2.1

Introduction

Senile emphysema is characterized by distal airway enlargement without obvious fibrosis
or alveolar wall destruction.1 Other structural components of senile lung include the loss
of elastic fibers, thickening of alveolar walls1, and diminished pulmonary elastic recoil.2-4
In concert with the pathological changes that accompany aging, increased residual volume
(RV), functional residual capacity (FRC) 5, and decreased diffusing capacity of carbon
monoxide (DLCO) 5, forced expiratory volume in 1 sec (FEV1), and forced vital capacity
(FVC) 6 are also observed.
Senile emphysema is often considered to be a misnomer, as subjects do not express the
same clinical symptoms of emphysema, and this condition is more appropriately referred
to as the senile lung. 7 Specifically, emphysema as found in chronic obstructive pulmonary
disease (COPD) is differentiated structurally from senile lung by the deformation of alveoli
as a result of fibrosis and tissue destruction, resulting in reduced surface area for gas
exchange.8 Importantly, subjects with senile lung appear to have sufficient lung function
for their normal day-to-day activities.9 These changes do however increase the risk of
breathlessness and respiratory failure in the elderly when compromised, and further
complicate health when combined with cardiac impairment or respiratory infection.10-12
Specifically, these age-dependent structural and functional changes can reduce sensitivity
of the respiratory centres in the presence of hypoxia or hypercapnia, resulting in a
diminished ventilatory response in cases of heart failure or aggravated airways
obstruction.5,10,13

41

Although the changes associated with senile emphysema are histologically different from
COPD- related emphysema, they result in similar changes in lung compliance and function.
A consequence of the reduction in supporting tissues around the airways is a tendency for
the smaller airways to collapse. As a result, premature closure of these airways (<2mm)
becomes common during normal tidal breathing.
Hyperpolarized inhaled noble gas magnetic resonance imaging (MRI) provides noninvasive measurements of lung function and structure

14-19

showing those regions of the

lung that participate in ventilation and those that do not.19,20 In addition, the MRI apparent
diffusion coefficient (ADC) for an inhaled gas is sensitive to changes in the lung
microstructure and airspace size correlating well with age 17, spirometry 21, DLCO 22, and
x-ray computed tomography (CT) measurements of emphysema 23. Previous studies have
shown a close agreement between alveolar parameters obtained using the 3He MRI lung
morphometry technique and those found by direct histological analysis.24 Many of these
studies have shown a close link between elevated alveolar sheath dimensions and mean
linear intercept with pulmonary function measurements, in mild to severe cases of
COPD.24-26 As such, we hypothesize that older never-smokers will have a significantly
increased external airway radius (R) and mean linear intercept (Lm), as well as a decreased
alveolar sheath (h) as compared to younger never-smokers, that is similar to ex-smokers
with mild-to-moderate COPD.

2.2
2.2.1

Methods
Study Subjects and Design

Participants provided written informed consent to the study protocol approved by the local
research ethics board and Health Canada. An older never-smoker group of subjects (60-90
years of age) with ≤ 0.5 pack year smoking history and without acute or chronic respiratory
disease, as well as a comparator ex-smoker group, were evaluated using spirometry,
plethysmography, hyperpolarized 3He MRI and CT during a single visit.
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2.2.2

Pulmonary Function Measures

Spirometry was performed to acquire the forced expiratory volume in one second (FEV1),
forced vital capacity (FVC), and FEV1/FVC according to American Thoracic Society
(ATS) guidelines (MedGraphics Corporation, St. Paul, Minnesota, USA).27 Body
plethysmography was performed for the measurement of lung volumes, and DLCO was
measured using the gas analyzer (MedGraphics, St. Paul, MN).

2.2.3

Image Acquisition Parameters

MRI was performed on a whole body 3T MRI system (MR750 Discovery, GEHC,
Milwaukee, WI) with broadband imaging capability. All 3He MRI employed a whole body
gradient set with maximum gradient amplitude of 4.8 G/cm and a single-channel, rigid
elliptical transmit/receive chest coil (RAPID Biomedical GmbH, Wuerzburg, Germany).
The basis frequency of the coil was 97.3 MHz and excitation power was 2 kW using an
AMT 3T90 RF power amplifier (GEHC). Subjects were positioned supine in the scanner
and for both 1H and 3He MRI, subjects were instructed by a pulmonary function
technologist to inhale a gas mixture from functional residual capacity (FRC), and image
acquisition was performed under breath-hold conditions. Proton MRI and 3He static
ventilation images were acquired as previously described.18 The data for in vivo lung
morphometry were acquired using a multi-slice 2D gradient echo diffusion weighted
sequence with a matrix size of 128x80, for each of seven 30mm coronal slices (flip angle
θ = 4°, TE = 1.2 ms, TR=4.7 ms, b= 0, 1.6, 3.2, 4.8, 6.4 s/cm2); the diffusion-sensitization
gradient pulse ramp up/down time = 500 μs with a diffusion time = 1460 μs and no gap
between lobes. All five interleaved sets of images were acquired during a single breathhold.
Thoracic CT was acquired on a 64-slice Lightspeed VCT scanner (GEHC) (64 × 0.625
mm, 120 kVp, 100 effective mA, tube rotation time of 500 msec, and a pitch of 1.0). A
single spiral acquisition of the entire lung was acquired from the apex to the base with
subjects in the supine position and in breath-hold after inhalation of a 1.0 L 4He/N2 mixture
from FRC. Images were reconstructed using a slice thickness of 1.25 mm with a standard
convolution kernel. The total effective dose for an average adult was 1.8 mSv.
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2.2.4

Image Analysis

Ventilation defect percent (VDP) measurements were generated by one observer using
semi-automated segmentation software as previously described.28 3He MRI ADC analysis
was performed using MATLAB R2013b (MathWorks, Natick, MA). To ensure that ADC
was generated for voxels corresponding to ventilated lung regions, a k-means clustering
algorithm, developed previously for 3He MRI segmentation28, was applied to the
nondiffusion-weighted images (b= 0 s/cm2) to obtain a binary mask for each slice. The
resulting binary masks were then applied to the corresponding diffusion-weighted images
(b= 1.6 s/cm2), and the ADC maps were generated on a voxel-by-voxel basis. The relative
area of the CT density histogram with attenuation values less than −950 Hounsfield units
(RA950) was determined using Pulmonary Workstation 2.0 (VIDA Diagnostics Inc.,
Coralville, IA). A CT density threshold for emphysema of RA950 greater than 6.8% was
used based on a previous study that reported this value as the upper 95% limit of predicted
normal values.29

2.2.5

Lung Morphometry Calculation

As previously described30, external (R) and internal (r) airway radius parametric maps were
computed from diffusion-weighted data on a pixel-by-pixel basis using a custom-built IDL
6.4 algorithm which searched for the global minimum to determine longitudinal (𝐷𝐿 ) and
̅ ) and anisotropic (𝐷𝑎𝑛 ) diffusion
transverse (𝐷𝑇 ) diffusion coefficients from mean (𝐷
coefficients. To extract diffusion coefficients, the conditions 𝑏𝑚𝑎𝑥 𝐷𝑎𝑛 >1 and 𝑏𝑚𝑎𝑥 𝐷𝑇 > 1
must be met, where 𝑏𝑚𝑎𝑥 is the maximum b-value in the experiment. These constraints
define the minimal gradient strength necessary for extracting the diffusion coefficients DL
and DT from the multiple b-value MR experiments, while maintaining a constant diffusion
time for each b-value acquisition.31 The free diffusion coefficient of 3He gas in lung
airspaces (D0) was determined to be concentration-independent and assumed to be 0.84
cm2/s. All morphometry modelling was performed within the physiological range of
r/R>0.4. Estimates of alveolar density (𝑁𝑎 ), surface area-to-volume ratio (S/V) and mean
linear intercept (𝐿𝑚 ) were also generated as previously described.24
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2.2.6

Statistical Analysis

Measurement comparisons were performed using a Wilcoxon matched-pairs two-tailed ttest using IBM SPSS Statistics 20.00 (SPSS, Chicago, IL). Multiple comparisons were
evaluated using the Kruskal-Wallis test with Dunn’s correction while relationships
between morphometry and spirometry measurements were evaluated using linear
regression (R2) analysis (least squares method) performed using GraphPad Prism 4.01
(GraphPad Software, La Jolla, CA; 2004); best fit lines and the corresponding 95%
confidence intervals were determined. Results were considered statistically significant
when the probability of making a Type I error was less than 5% (p < 0.05).

2.3
2.3.1

Results
Subject Demographics and Pulmonary Function Measurements

Forty-two older never-smokers (73±6yrs, 19 males) and a comparator group consisting of
25 age-matched ex-smokers (71±10yrs, 18 males) were enrolled in the study. Table 2-1
shows subject demographics as well as pulmonary function test results for all subjects.
Significant differences were observed between the two groups for FEV1 (p=.001),
FEV1/FVC (p<.001), RV (p=.009) and DLCO (p<.001). There were no significant
differences (p>.05) in Age, BMI, FVC, TLC and RV/TLC between the two groups.
Table 2-1: Subject Demographics
Significance
of difference
(p-value)
Sex (male)
19
18
ns
Age (yrs)
73 (6)
71 (10)
ns
27 (4)
28 (5)
BMI (kg · 𝑚−2 )
.001
FEV 1%pred
107 (17)
88 (28)
ns
FVC %pred
103 (15)
97 (21)
<.001
FEV1/FVC %
77 (6)
66 (14)
.009
RV %pred
98 (22)
118 (39)
ns
TLC %pred
101 (13)
100 (27)
ns
RV/TLC %pred
97 (16)
108 (35)
<.001
DLCO %pred
90 (16)*
67 (26)
SD, standard deviation; BMI, body mass index; FEV1, forced expiratory volume in 1
second; %pred, percent predicted; FVC, forced vital capacity; RV, residual volume; TLC,
total lung capacity; DLCO, diffusing capacity of the lung for carbon monoxide. *n=39
Parameter
(SD)

Older Never-Smokers
(n=42)

Ex-Smokers
(n=25)
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2.3.2

Imaging Measurements

Figure 2-1 shows the central coronal 3He static ventilation and morphometry maps for a
representative older never-smoker and an ex-smoker. Difference in shape of static
ventilation images as compared to morphometry maps can be explained by differences in
slice thickness between static ventilation and diffusion-weighted images. Table 2-2 shows
3

He MR measurements as well as the CT surrogate measure of emphysema (RA950) for all

subjects. All 3He ventilation (VDP), diffusion (ADC,𝐷𝐿 , and 𝐷𝐿 ) and morphometry (R, r,
h, Lm, Na, S/V) measurements, as well as CT-derived RA950 were significantly different
between the two groups. In addition, when compared to literature reported values for a
small group of younger never-smokers, using both CT and the 3He morphometry technique,
older never-smokers appeared to have a greater acinar duct radius (R= 330 and 300µm
respectively) and mean linear intercept (h=240 and 210µm), although sample size was not
large enough to show significance.24,32
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Figure 2-1: 3He Centre Slice Static Ventilation and Morphometry Maps.
Hyperpolarized 3He static ventilation and morphometry maps for an older never-smoker
(f, 77yr) and an ex-smoker (f, 67yr). R, external airway radii; r, internal airway radii; h,
alveolar sheath; Lm, mean linear intercept; Na, alveolar density.
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Table 2-2: 3He MRI Ventilation, ADC, Lung Morphometry and CT measurements
Significance of
difference
(p-value)
VDP (%)
3 (2)
15 (11)
<.001
ADC
0.29 (0.03)
0.34 (0.06)
<.001
0.81 (0.17)*
0.59 (0.19)
<.001
𝐷𝐿
0.32 (0.07)*
0.46 (0.08)
<.001
𝐷𝑇
R (µm)
327 (4)*
336 (14)
<.001
r (µm)
205 (3)*
227 (12)
<.001
h (µm)
122 (4)*
109 (16)
<.001
Lm (µm)
244 (4)*
272 (14)
<.001
-3
Na (mm )
103 (3)*
95 (14)
.003
-1
⁄
163
(3)*
147
(7)
<.001
𝑆 𝑉 (cm )
RA950 (%)
0.73 (0.75)
7.4 (9.1)
<.001
VDP, ventilation defect percent; ADC, apparent diffusion coefficient;𝐷𝐿 , longitudinal
diffusion coefficient; 𝐷𝑇 , transverse diffusion coefficient; R, external airway radius; r,
internal airway radius; h, alveolar sheath; Lm, mean linear intercept; Na, alveolar density;
S/V, surface area-to-volume ratio; RA950, relative area under -950 Hounsfield units. *n=40
Parameter
(SD)

Older Never-Smokers
(n=42)

Ex-Smokers
(n=25)

As shown in Figure 2-2, for older never-smokers (NS), external airway radius (R) was
significantly smaller (p<.05), alveolar sheath (h) was significantly greater (p<.05), and
alveolar density (𝑁𝑎 ) was significantly greater (p<.05) than that of ex-smokers without
emphysema (ES (w/oE)), but was not significantly different from ex-smokers with CT
evidence of emphysema (ES (E)). Internal airway radius (r) and mean linear intercept (𝐿𝑚 )
were both significantly smaller in NS than either ES (E) (p<.05 and p<.01 respectively)
and ES (w/oE) (p<.0001 and p<.0001 respectively) which were not different from each
other. Finally, surface area-to-volume ratio (S/V) was significantly greater in NS than both
ES (E) (p<.01) and ES (w/oE) (p<.0001).
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Figure 2-2: 3He Magnetic Resonance Morphometry Measurements. NS, older neversmokers; ES, ex-smokers; E, emphysema; w/o E, without emphysema. For all plots the box
extends from the 25th to 75th percentiles while the whiskers are min and max values.
Never-smokers, n=40, ex-smokers without emphysema, n=17, and ex-smokers with
emphysema, n=7.
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*Significance of difference (p<.05) determined using Kruskal-Wallis test along with
Dunn’s correction.

2.3.3

Morphometry Relationships with Pulmonary Function and CT

The Pearson correlation coefficients between 3He morphometry measurements (R, r, h,
Lm, Na, and S/V) and both FEV1/FVC and DLCO for both older never-smokers and exsmokers are shown in Table 2-3. External airway radius (R) was significantly correlated
with FEV1/FVC (r=0.50, p<.05) and DLCO (r=0.58, p<.01) in the ex-smoker group only.
Internal airway radius (r) was significantly correlated with FEV1/FVC (r=0.46, p<.01)
only in the never-smoker group. Alveolar sheath (h) was not significantly correlated with
FEV1/FVC or DLCO in either group. Mean linear intercept (Lm) was significantly
correlated with FEV1/FVC (r=0.44, p<.01) and in the never-smoker group only.
Analogous to R, alveolar density (Na) was significantly correlated with FEV1/FVC (r=0.48, p<.05) and DLCO (r=-0.54, p<.01) in the ex-smoker group only. Lastly, similar to r,
surface area-to-volume ratio (S/V) was significantly correlated with FEV1/FVC (r=-0.43,
p<.01) in the never-smoker group only.
Table 2-3: 3He MR Morphometry Correlations with Pulmonary Function Measures
Pearson Correlation Coefficients, r (p-value)
Older Never-Smokers (n=40)
Ex-Smokers (n=25)
FEV1/FVC
DLCO
FEV1/FVC
DLCO
R (µm)
ns
ns
0.50(<.05)
0.58(<.01)
r (µm)
ns
ns
ns
0.46(<.01)
h (µm)
ns
ns
ns
ns
Lm (µm)
ns
ns
ns
0.44(<.01)
Na (mm-3)
ns
ns
-0.48(<.05)
-0.54(<.01)
ns
ns
ns
𝑆⁄𝑉 (cm-1)
-0.43(<.01)
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; DLCO, diffusing
capacity of the lung for carbon monoxide percent predicted; R, external airway radius; r,
internal airway radius; h, alveolar sheath; Lm, mean linear intercept; Na, alveolar density;
S/V, surface area-to-volume ratio
Figure 2-3 shows linear regressions for the longitudinal (DL) and transverse (DT) diffusion
coefficients with FEV1/FVC and DLCO for both older never-smokers and ex-smokers
independently. Both DL and DT were significant predictors of FEV1/FVC in the older
never-smokers (R2=0.19, p<.01, R2=0.13, p<.05) and the ex-smoker groups (R2=0.31,
p<.01, R2=0.40, p<.01) respectively. DL was also determined to be a significant predictor
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of DLCO in the ex-smoker group (R2=0.55, p<.0001), but was not a significant predictor in
the older-never smoker group. Likewise, DT was a significant predictor of DLCO in the exsmoker group (R2=0.56, p<.0001) only.
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Figure 2-3: Relationships between 3He Diffusion Coefficients with Pulmonary
Function Test Measurements. Scatterplots show linear regressions for longitudinal (DL)
and transverse (DT) diffusion coefficients with FEV1/FVC and DLCO for both older neversmokers and ex-smokers. Dotted lines indicate the 95% limits of agreement.

2.4

Discussion and Conclusions

To better understand the senile lung and the morphometric changes with age, we evaluated
a group of older never-smokers as well as a small group of ex-smokers using
hyperpolarized 3He diffusion weighted MRI and made the following observations: 1) older
never-smokers appeared to have increased airway radius and mean linear intercept as
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compared to literature reported values for younger never-smokers, 2) older never-smokers
had significantly lower external and internal airway radius and mean linear intercept, but
higher alveolar sheath thickness, alveolar density and surface area-to-volume ratio than exsmokers, 3) DLCO was not significantly related to morphometry measurements in older
never-smokers, while FEV1/FVC was significantly related, and, 4) both DL and DT were
significant predictors of FEV1/FVC in the older never-smokers, but not DLCO.
As expected, older never-smokers had relatively normal pulmonary function measurements
based on percent predicted values (FEV1/FVC=70%, FEV1/FVC%pred=103%). When
compared to literature reported values for younger never-smokers, we observed increased
ADC,17,33 lower alveolar depth and greater Lm in this group of older never-smokers.24 The
low variance in morphometry measurements among older never-smokers as compared to
ex-smokers in this study supports the notion that senile emphysema affects all healthy
aging adults to a similar extent when exposed to minimal environmental hazards.
Although elevated compared to literature values for younger never-smokers, the older
never-smokers in this study presented with smaller airspaces as compared to the ex-smoker
group, which was evident by a lower mean ADC and RA950 measurement for all subjects.
Further supporting these findings is the fact that older never-smokers had a greater alveolar
depth than the ex-smoker group, as well as a higher S/V and lower Lm (Table 2-2 & Figure
2-4). Interestingly, when comparing never-smokers with ex-smokers with, and without, CT
evidence of emphysema, these observations remained significant, and we observed the
same differences in morphometry measurements with the exception of h, which was not
different between the never-smoker and ex-smoker with emphysema groups. Although
alveolar depth was not significantly different, this may be due to the small sample size of
ex-smokers with emphysema in this study, as the difference between the two groups was
not significant by a very fine margin, and may have been exaggerated by an outlier with
abnormally large h in the ex-smoker group. As the 3He lung morphometry technique is
used to determine acinar geometry, there are several potential mechanisms for the observed
loss of alveolar depth in ex-smokers as compared to healthy older subjects.
Emphysematous enlargement of the acinar duct can produce flattening of the alveolus and
retraction of the alveolar septa.34 The increased alveolar depth and S/V in older never-
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smokers as compared to younger never-smokers35 can presumably be attributed to a loss
of elastin or change in collagen content, organization and/or distribution with age.36,37
Moreover, these differences may be explained by the active inflammatory response present
in patients with COPD, as would be expected in this group of ex-smokers. This
inflammatory component could lead to a thickening of the alveolar walls and septa,
effectively reducing the alveolar depth. In addition, the increased acinar duct radius in this
group of ex-smokers could indicate an increase in the number and size of pores in the
alveolar walls, as they would allow for increased diffusion between adjacent alveoli and
acinar ducts.38 Taken together, these findings suggest that in the senile lung, there may be
no active inflammatory component, or change in size or quantity of pores of Kohn
(fenestrae) as seen in emphysematous lungs.

Figure 2-4: Schematic of Airway Parameters for a Representative Older Neversmoker and Ex-smoker. Comparison of internal (r) and external (R) airway radius, as well
as alveolar sheath depth (h), showing diminished alveolar depth in ex-smokers.
While DLCO in older never-smokers was not significantly related to any of the
microstructural parameters measured, three in particular (r, Lm, and S/V) were significantly
related to FEV1/FVC. The lack of correlation with DLCO in this study is not too surprising
as the older never-smokers may have lacked the gross tissue destruction present in COPDrelated emphysema that could reduce the gas exchange area sufficiently to alter the
diffusive capacity of the lung.34 Furthermore, the apparent normalcy of DLCO in this group
of older never-smoker subjects (approximately 90% predicted) implies that this technique
has the potential to be used to detect significant changes in acinar airway geometry, even
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in individuals with clinically normal pulmonary function results. By the same token, the
especially low RA950 values for these older never-smokers, in the presence of elevated Lm
as compared to younger never-smokers, implies that the 3He lung morphometry technique
has greater sensitivity to early emphysematous changes (airspace enlargement) than does
traditional chest CT scoring practices.
Altogether, these findings do not rule out the possibility that environmental factors may
play a role in accelerating these changes. For that reason, the technique has considerable
potential as an outcome measure for the study of environmental agents such as tobacco
smoke or various other pollutants, as well as pharmaceuticals and potential disease
therapies or treatments.
In summary, in this small study of older never-smokers, we observed enlarged airspaces as
compared to younger never-smokers, while not quite as enlarged as that of ex-smokers.
These results, along with a greater observed alveolar density, greater alveolar depth and
greater S/V in older never-smokers compared to ex-smokers, support the notion that senile
lung does not involve fibrosis or tissue destruction. It implies that the mean airspace size
increases with age throughout adult life and is larger in current and past smokers than in
healthy never-smokers. The divergence of ex-smokers from older never-smokers is likely
a result of accumulated alveolar wall damage and the partial merging of alveoli due to
environmental aggravation over time. Ultimately, these results demonstrate that MRI has
the potential to replace histology and lung stereology as the gold standard for non-invasive
measurements of pulmonary acinus microstructure.
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CHAPTER 3: CONCLUSIONS AND FUTURE WORK

3

In this final chapter, I will provide an overview and summary of the important findings
and conclusions of Chapter 2. I will also address the limitations of the hyperpolarized
gas MRI lung morphometry technique presented and provide some potential solutions.
Finally, based on the findings and limitations discussed, I will outline a roadmap for
future studies.

3.1

Overview and Summary

Senile emphysema is characterized by distal airway enlargement without obvious fibrosis
or alveolar wall destruction.1 Other structural components of senile lung include the loss
of elastic fibers, thickening of alveolar walls1, and diminished pulmonary elastic recoil.2-4
As patients do not present with the clinical symptoms of emphysema, senile emphysema
is more correctly identified as senile lung.5 Emphysema, as linked to chronic obstructive
pulmonary disease (COPD), is unique from senile lung in that the presence of fibrosis and
tissue destruction leads to deformation of the alveoli.6
Subjects with senile lung appear to have sufficient lung function for their normal day-today activities,7 however these changes tend to increase the risk of breathlessness and
respiratory failure in the elderly when compromised. Further complications in health result
when these changes are concomitant with cardiac impairment and/or respiratory infection.810

These age-dependent structural and functional changes can reduce sensitivity of the

respiratory centres to hypoxia or hypercapnia, resulting in a diminished ventilatory
response in cases of heart failure or airway obstruction.8,11,12 As a consequence of the
reduction in supporting tissues and tethering forces around the airways with age, there is a
tendency for the smaller airways to collapse. Accordingly, premature closure of these
airways becomes common during normal tidal breathing.
Stereological techniques have historically been used to measure pulmonary morphometry,
and as such the technique has become the gold standard for exploring the structural changes
associated with various pulmonary diseases. Emphysema has commonly been studied
using these techniques, however most work has ignored the effects of septal destruction,
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and looked solely at airspace enlargement.13 Alternatively, micro–CT has rapidly emerged
as an imaging technique with the potential to measure lung microstructure on length scales
much smaller than previously possible with clinical CT scanners. This technology
consequently offers the ability to analyze acinar morphometry without the need for
physical segmentation, thus maintaining an undamaged, three-dimensional (3-D)
structure.14 Unfortunately, due to the long exposure time and high dose associated with this
technique, scanning living organisms is difficult, if not altogether impossible.
Unfortunately, with both of these techniques, choice of inflation and fixation techniques
introduce a number of errors and biases.15 As such, a non-invasive imaging method that
can evaluate both lung structure and function without the use of ionizing radiation or tissue
fixation/preparation is required.
Hyperpolarized inhaled noble gas MRI provides non-invasive measurements of lung
function and structure 16-21 showing those regions of the lung that participate in ventilation
and those that do not.21,22 In addition, the MRI ADC for an inhaled gas is sensitive to
changes in the lung microstructure and airspace size correlating well with age
spirometry

23

, DLCO

24

, and CT measurements of emphysema

25

19

,

. Previous studies have

shown a close agreement between alveolar parameters obtained using the 3He MRI lung
morphometry technique and those measurements found by direct histological analysis.26
In Chapter 2 we quantitatively evaluated a group of 42 older never-smokers and 25 exsmokers using hyperpolarized 3He diffusion weighted MRI. The acinar duct morphometry
results were found to be within the physiological range reported in literature. Calculated
values of internal (r) and external (R) airway radius as well as mean linear intercept (Lm)
for individual subjects were similar with low variance. Results showed that MRI
measurements of lung airspace size in healthy older never-smokers were elevated
compared to previous results reported in younger never-smokers. Such results are
consistant with senile emphysematous changes to healthy parenchyma that accompanies
aging. Furthermore, this study showed that there was a greater observed alveolar density,
greater alveolar depth and greater surface area-to-volume ratio in older never-smokers as
compared to ex-smokers, supporting the notion that senile lung does not involve fibrosis
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or tissue destruction. These results suggest MRI has the potential to replace lung stereology
as the gold standard for measuring pulmonary acinus microstructure.

3.2

Limitations of Current Work

A number of limitations currently affect the potential clinical translation of this technique.
Firstly, 3He MRI requires unique expertise and equipment. There is an extremely limited
supply of helium gas, making further follow-up studies and clinical implementation of this
technique questionable. With regards to the polarization itself, the process is dependent on
expensive equipment that relies heavily on highly skilled operators who can handle,
prepare, and administer the gas in a time-sensitive manner.
In addition to the physical limitations, there is still room for improvement in modelling
pulmonary morphometry. As was evident in this study, algorithm optimization is still
required as not all diffusion data could be successfully fit to the model each subject.
Furthermore, although more time efficient than lung stereology, MRI morphometry still
requires manual observer interaction and is computationally intense. The model itself
typically requires between 2-3 hours of runtime per subject per slice, depending on the
complexity of the data. Fortunately, multiple instances of the program can be run in
parallel, significantly shortening the overall processing time for large data sets.
Specific to this technique, the morphological equations are quantitatively valid in the
physiologically important range of the airways parameters characteristic of healthy lungs
and those with mild emphysema. However, when acinar airways deviate significantly from
this range, in the case of severe emphysema, the “cylindrical” model is expected to fail. In
lungs with advanced emphysema, our results might provide only the “apparent” diffusion
characteristics. Furthermore, for lungs with substantial degeneration of the acinar walls,
the model requires further generalization in order to account for the expansion of large air
cavities in which 3He diffusion is much less restricted. A further limitation results from the
assumption at the base of the diffusion/morphometry relationship (R, r, and h) which
presumes that the diffusing 3He atoms cannot penetrate through alveolar walls. In reality
though, alveolar walls have pores, however their effects on DL and DT are considered
negligible in healthy subjects due to the small number of microscopic (<10 μm) pores
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present.27 In the emphysematous lung, this assumption weakens, as more pores of variable
size (>20 μm) occur in alveolar walls, ultimately increasing the transverse and longitudinal
ADCs .28 These effects fall beyond the scope of this study, and will need to be addressed
in future studies. All things considered, these measures are still capable of providing a
wealth of information regarding emphysematous progression when interpreted in the
context of disease severity.
One other limitation of this study is the lack of data collected from other imaging modalities
or techniques in conjunction with 3He MRI. Both micro-CT and stereological data could
have been used to validate the measurements acquired using this technique, however these
procedures were infeasible due to their highly invasive nature and would have required
biopsies or cadaveric samples.

3.3

Future Work

The results and discussions presented in this thesis provide some important insights
regarding the use and applicability of the hyperpolarized 3He morphometry technique in
developing a deeper understanding of the structural and functional changes that occur
during the normal lung aging process. In order for this technique to supplant the current
invasive gold standard of lung stereology, there is a need for further development into the
automation and removal of all user interaction with processing the diffusion weighted
image data.
Additionally, due to the limited availability and high cost of 3He gas, its clinical translation
will become increasingly difficult in the coming years. As such, future studies comparing
3

He-derived morphometry measurements with

129

Xe-derived measurements will be of

great importance. 129Xe gas is more abundant and as such substantially cheaper than 3He,
hence making it a more realistic option as an imaging agent in clinical applications. Recent
studies have begun assessing pulmonary microstructure using

129

Xe in healthy young

subjects and those with mild COPD29, however, due to the differences in the physical
properties between the two gases, it is not known how these results would differ when
assessing an older never-smoker population. Furthermore, application of a 129Xe diffusion
weighted technique will provide unique information on the relationship between lung
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morphometry and pulmonary perfusion. The unique property of 129Xe to perfuse from the
acinus into the surrounding capillaries would provide a better understanding of the relative
stability of DLCO with age even in the presence of senile emphysema.
Finally, while this work has focused on mean values of 3He diffusion morphometry values,
this approach ignores a major benefit of the imaging technique, namely the ability to
acquire regional pulmonary information or data from follow-up texture analysis
information. The heterogeneity of disease across the lung has been shown previously in
subjects with asthma and COPD, and thus having a regional understanding of senile lung
may help elucidate the nature and potential patterns present in the age-related increase in
airspace. Future efforts to analyze this distribution would likely be informative, potentially
enabling identification of different senile lung phenotypes based on patterns of lung
abnormalities.
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